AI assistant
WESTMINSTER GROUP PLC — Capital/Financing Update 2019
Mar 1, 2019
8019_rns_2019-03-01_84d8c958-83e4-437d-9409-203df6fe35cc.html
Capital/Financing Update
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 6228R
National Westminster Bank PLC
01 March 2019
National Westminster Bank Plc - Transfer of Agent
Notice in relation to the National Westminster Bank Plc ("NatWest Bank") £3,000,000,000 Euro Medium Term Note Programme
National Westminster Bank Plc gave notice that it has terminated the appointment of Deutsche Bank AG, London Branch as Principal Paying Agent and Deutsche Bank Luxembourg SA as Paying Agent, Transfer Agent and Registrar for NatWest Bank in connection with the 400,000,000 Fixed / Floating Rate Undated Subordinated Notes (ISIN: XS0102480869) issued under the Programme, the €100,000,000 Floating Rate Undated Subordinated Step-up Notes (ISIN: XS0102480786) issued under the Programme and the £200,000,000 Undated Subordinated Step-up Notes (ISIN: XS0102493680) issued under the Programme (these notes are hereinafter together referred to as the "Notes") with effect from 29 March 2019 (the "Termination Date") and that The Bank of New York Mellon, London Branch (contact details below) has been appointed as the successor Principal Paying Agent and Paying Agent and The Bank of New York Mellon SA/NV, Luxembourg Branch (contact details below) has been appointed as the successor Transfer Agent and Registrar, with effect from the date immediately following the Termination Date.
For further information, please contact:
Scott Forrest
Head of RBS Debt Capital Markets & Capital Strategy
Tel: +44 (0) 20 7678 5313
Legal Entity Identifier
National Westminster Bank Plc - 213800IBT39XQ9C4CP71
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
MSCUGUMGWUPBGPG